A graphical procedure for determining the specific activity of radiolabeled ligands has been developed for use with radioimmunoassays.
Although with this procedure we utilize the same experimental information required for displacement analysis, we are also able to determine both the specific activity and the binding constants of the labeled and unlabeled materials without assuming that these constants are equal; the concentration of antibody-binding sites can also be calculated. Thus, this graphical technique permits calculation of additional information without additional experimentation. We applied this procedure to the labeled materials used in a thymopoietin assay, testing two different preparations of radiolabeled material, and saw negligible differences between the two. The specific activity determined from the displacement analysis correlated well with that calculated by the graphical procedure.
The development of radioimmunoassays for thymopoietin as well as for many other substances requires a knowledge of the specific activity of the radiolabeled material.
For simple molecules this specific activity can be calculated gravimetrically, but for more complex substances such as proteins (e.g., thymopoietin), indirect methods are necessary. The classic indirect method for measuring specific activity is displacement analysis, in which it is assumed that the binding constant for the radiolabeled material is the same as that for the unlabeled material, i.e., for the native analyte. However, the researcher usually does not know whether the binding constants are identical. Measuring the binding constants requires knowledge of the specific activity of the labeled analyte and use of the Scatchard plot, and thus the researcher is caught in a dilemma:
he must know the binding constants to use the displacement analysis for determining the specific activity, but he cannot determine the binding constants from the Scatchard plot without knowing the specific activity. Therefore, he must proceed with a more complicated analysis involving simultaneous determination of the specific activity and the binding constants.
Currently, this involves non-linear least-squares fitting of the data to a mathematical model of the binding system.
Before one can understand the problems associated with the measurement of specific activity and binding constants, one must be acquainted with the models that define these quantities.
The 
Materials and Methods
Thymopoietin was isolated as described previously (5). Antibodies to thymopoietin were elicited in rabbits as described previously (6) .
lodination of Thymopoietin
We evaporated 2 mCi of 1251-labeled p-hydroxyphenylpropionic acid N-hydroxysuccinimide ester (Bolton-Hunter reagent, 1500 kCi/mol; New England Nuclear, Boston, MA 02118), to near-dryness in an ice bath at 0 #{176}C under a gentle stream of nitrogen. To the contents of the vial we added 5 g of thymopoietin (500 mg/L) in sodium borate buffer (0.1 mol/L, pH 8.5) and a "Reacti-Vial" magnetic stirring bar (Pierce Chemical Co., Rockford, IL 61105). After stirring the solution for 3 mm at 0 #{176}C, we added 0.5 mL of a 0.2 mol/L glycine solution in sodium borate buffer (0.1 mol/L, pH 8.5), and stirred the mixture at 0 #{176}C 15 mm longer.
Purification of 125l..labeled Thymopoietin
April preparation. Immediately after the iodination reaction was complete, we applied the mixture to a 0.6 X 30 cm column of G-25 Sephadex (Pharmacia, Uppsala, Sweden) previously equilibrated with 40 mL of a solution of 2.5 g of gelatin per liter of sodium phosphate buffer (50 mmol/L, pH 7.5). We eluted the radionuclides with the same sodium phosphate buffer in 0.5-mL fractions, and counted the radioactivity of each fraction with a gamma spectrometer for lOs.
Those fractions corresponding to the void volume were pooled and applied to a 0.9 X 60 cm column containing an equal mixture of G-50 Sephadex and G-75 Sephadex previously equilibrated with a 5 g/L solution of bovine serum albumin in phosphate buffer (50 mmol/L, pH 7.5). We collected 1-mL fractions and counted the radioactivity of each with a gamma spectrometer for 10 s. June preparation.
Immediately after the iodination and separation of the radionuclides on Sephadex G-25 were complete, we applied a volume corresponding to the void volume to a 0.9 X 60 cm column of diethylaminoethyl-Sephadex A-25 that previously had been equilibrated with tris(hydroxymethyl)methylamine.HCI buffer (50 mmol/L, pH 7.0). The iodination mixture was eluted with this buffer with a linear gradient of increasing ionic strength from the equilibration concentration to 1.0 mol/L. We collected 2-mL fractions in test tubes containing 200 L of bovine serum albumin (1 g/L in sodium phosphate buffer, 10 mmol/L, pH 7.4). The radioactivity of each fraction was counted for 10 s. We analyzed the fractions with peak radioactivity in each purification scheme for binding with excess anti-thymopoietin antibody.
Fractions with the highest specific binding and the lowest nonspecific binding (in the absence of antibody) were subsequently used in the radioimmunoassay.
Radioimmunoassay
All assays were performed in duplicate, in 12 X 75-mm polystyrene tubes. We added to each tube 0.2 mL of charcoal-treated human serum (i.e., serum treated with charcoal to remove endogeneous thymopoietin) and 0.2 mL of thymopoietin standard (0.5 to 16 ug/L) in assay buffer consisting of, per liter, 1 mg of bovine serum albumin, 0.15 mol of sodium chloride, and 10 mmol of sodium phosphate as buffer, pH 7.4. We then added to each tube 0.1 mL of '251-labeledthymopoietin and 0.5 mL of rabbit antithymopoietin serum that had been diluted with the same buffer. The tubes were agitated and allowed to equilibrate for 18 h at room temperature (23 #{176}C). To a second set of tubes were added 0.2 mL of charcoaltreated serum and 0.2 mL of assay buffer. We added 0.1 mL of 'I-labeled thymopoietin to duplicate tubes in six different increments, ranging from 7000 to 170 000 cpm and then added 0.5 mL of rabbit anti-thymopoietin serum solution to all tubes. These tubes were agitated and allowed to equilibrate for 18 h at room temperature (23 #{176}C). In both assays, antibody-bound '25I-labeled thymopoietin was separated from free 1251-labeled thymopoietin by adding 0.75 mL of a solution containing, per liter, 300 mL of polyethylene glycol 6000,0.15 mol of sodium chloride, and 10 mmol of sodium phosphate, as buffer (pH 7.4). The tubes were agitated, centrifuged at 1000 X g for 20 mm at room temperature (23 #{176}C), and the supernatant liquids were transferred to clean tubes. The radioactivity of the precipitates (bound) and the supernatant liquids (free) was counted with an automated gamma spectrometer.
To determine nonspecific binding, we substituted normal rabbit serum, appropriately diluted, in place of the antiserum.
Theoretical Development
The model for our graphical procedure is considered to have a single class of binding sites; i.e., these sites are either vacant, bound to labeled analyte, or bound to unlabeled analyte. However, the binding constant for the labeled material is assumed to be different from that for the unlabeled analyte. This difference can result because the labeling process chemically alters most analytes.
Hence The bound and free fractions of labeled analyte are measured as a function of the concentration of unlabeled analyte added to the system. The bound fraction is then corrected for the nonspecific binding of the labeled analyte added to the system. In the displacement analysis, the ratio of bound to total ana-lyte for the labeled analyte is plotted as a function of the labeled concentration in the first set of experiments and as a function of the unlabeled concentration in the second set of experiments.
The procedure we described requires a different set of plots.
The following equations quantitatively define the equilibrium in the assay with either both the labeled and unlabeled, or with only the labeled material present.
where: The concentrations of labeled analyte can be defined in terms of both specific activity (i.e., counts per mole) and the concentration of counts in the material.
where: The slope of the line obtained will be equal to K*/y, and (STY) will be equal to the s-axis intercept. is drawn, where the former value is plotted on the y-axis and the latter on the x-axis, the value of 1/'y will be equal to the slope of the line and the value of 1/K will be equal to the intercept on the y-axis.
In 
Results and Discussion
(10) Because the thymopoietin radioimmunoassays were performed with two different preparations of the 125I-labeled peptide, the two assays will be discussed separately.
However, for both assays there was some nonspecific binding of the labeled analyte to material in the assay system. Thus, in all experiments the actual radioactivity of the bound fraction was Figure 1 shows the experimental data obtained for the latabulated in Table 1 . beled thymopoietin with the first set of materials plotted acBased on the graphical interpretation of the data for the cording to the Scatchard equation (equation 10). The data April experimelits, the binding constants for the labeled and generated a good linear plot. The value for the slope is given unlabeled analyte were possibly the same, within experimental as K*/Y and the intercept is given as STY in Table 1 (as deerror (error will be discussed later). The specific activity for fined by equation 10). We then used the slope and intercept the labeled analyte was 4.76 X l0 cpm/nmol, which is values in the calculation of the variables to be plotted in the equivalent to 30.1 sCi/nmol, based on the efficiency of the second graph (Figure 2) . The known thymopoietin concengamma spectrometer. tration and the bound and free radioactivity for the standard In June, experiments were performed similar to those in curve are used. Again, the linearity of the plot was good, with April, except that we used a different preparation of the lathe slope shown as l/y and the intercept as 1/K in Table 1. haled thymopoietin. Figure 3 shows the Scatchard plot for the From these four values (two intercepts and two slopes) we can June data. The line is defined by three or four points with high values for the bound-to-free ratios. This slope and intercept _______________________________________________________ are listed in Table 1 . The line used in the calculations is weighed for a bound-to-free-ratio of 0.6. Fig. 6 . Total radioactivity applied as a function of the thymopoietin concentration as determined from Fig. 5 preparation, as defined by the slope in Figure 4 , was less than that of the April preparation.
Displacement Analysis
Besides the analysis developed in this paper, we also used the displacement analysis to determine the specific activity for the April and June data. The standard curve for the April data is plotted in Figure 5 . Several B/T values for the experiments with only the labeled material are indicated on this figure, and the concentration of thymopoietin corresponding to this B/T is read from the abscissa. In Figure 6 the thymopoietin concentrations obtained from Figure 5 are plotted as a function of the total radioactivity added in each experiment. The slope of the line in Figure 6 corresponds to the specific activity of the labeled thymopoietin.
The calculated value of the specific activity from this displacement analysis was 4.38 X 10 cpm/nmol, which agrees well with the value of 4.76 X iO cpm/nmol calculated by the new graphical method. This lower value obtained from the displacement analysis is expected because the binding constant for the labeled material could exceed that for native thymopoietin so that it would take a greater amount of native material than labeled analyte to obtain the same value of B/T in the displacement analysis. The specific activity from the displacement analysis for the June experiments is 1.26 X i0. cpm/nmol, which is higher than that determined by our graphical method. Again, this might be expected, because the binding constant for unlabeled thymopoietin probably exceeded that of the labeled thymopoietin. 
